Given that IL-11 is overexpressed and promotes radioresistance in cervical cancer, IL-11 might serve as an attractive candidate to predict radiosensitivity and is a potential therapeutic target for cervical cancer. This evidence concerns the gene IL11 and cervical carcinoma.